ArticleJournal of Cancer2022

Inducing Synergistic DNA Damage by TRIP13 and PARP1 Inhibitors Provides a Potential Treatment for Hepatocellular Carcinoma.

Haojun Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.